Smolen, Josef S ;
Landewe, Robert ;
Bijlsma, Johannes...
Smolen , J S , Landewe , R , Bijlsma , J , Burmester , G , Chatzidionysiou , K , Dougados , M , Nam , J , Ramiro , S , Voshaar , M , van Vollenhoven , R , Aletaha , D , Aringer , M , Boers , M , Buckley , C D , Buttgereit , F , Bykerk , V , Cardiel , M , Combe , B , Cutolo , M , van Eijk-Hustings , Y , Emery , P , Finckh , A , Gabay , C , Gomez-Reino , J , Gossec , L , Gottenberg , J-E , Hazes , J M W , Huizinga , T , Jani , M , Karateev , D , Kouloumas , M , Kvien , T , Li , Z , Mariette , X , McInnes , I , Mysler , E , Nash , P , Pavelka , K , Poor , G , Richez , C , van Riel , P , Rubbert-Roth , A , Saag , K , da Silva , J , Stamm , T , Takeuchi , T , Westhovens , R , de Wit , M & van der Heijde , D 2017 , ' EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs : 2016 update ' , Annals of the Rheumatic Diseases , vol. 76 , no. 6 , pp. 960-977 . https://doi.org/10.1136/annrheumdis-2016-210....
,
2017
